INFO:
This study analyzed tumour microenvironment (TME) features and circulating biomarkers to understand patient responses to nivolumab plus cabozantinib versus suni
Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC - ecancer